The U.S. Federal Trade Commission (FTC) is looking into whether baby-formula makers, including Abbott Laboratories (NYSE: ABT), Reckitt Benckiser (OTC ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE